(Source: Axovant Sciences Ltd) Axovant Sciences Announces Presentations and Sponsored Symposium at the 2016 Alzheimer's Association International Conference HAMILTON, Bermuda, July 18, 2016 /PRNewswire/ -- Axovant Sciences Ltd. (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, announced today that the company will host a symposium and make four poster presentations at the 2016 Alzheimer's Association International Conference (AAIC) being held in Toronto July 24-28. 'Our presence at this year's AAIC highlights our progress towards building a leading pipeline of potential treatments for patients with dementia,' said Vivek Ramaswamy, CEO of...
↧